Guided Therapeutics (GTHP) Share-based Compensation (2016 - 2025)

Guided Therapeutics' Share-based Compensation history spans 15 years, with the latest figure at $25000.0 for Q4 2025.

  • On a quarterly basis, Share-based Compensation rose 292.31% to $25000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $55518.0, a 183.6% increase, with the full-year FY2025 number at $377000.0, up 214.17% from a year prior.
  • Share-based Compensation hit $25000.0 in Q4 2025 for Guided Therapeutics, up from $15118.0 in the prior quarter.
  • Over the last five years, Share-based Compensation for GTHP hit a ceiling of $1.1 million in Q2 2023 and a floor of -$821353.0 in Q4 2022.
  • Historically, Share-based Compensation has averaged $62996.2 across 5 years, with a median of $21091.5 in 2023.
  • Biggest five-year swings in Share-based Compensation: crashed 1742.71% in 2022 and later surged 2443.18% in 2023.
  • Tracing GTHP's Share-based Compensation over 5 years: stood at $50000.0 in 2021, then crashed by 1742.71% to -$821353.0 in 2022, then soared by 93.43% to -$54000.0 in 2023, then skyrocketed by 75.93% to -$13000.0 in 2024, then soared by 292.31% to $25000.0 in 2025.
  • Business Quant data shows Share-based Compensation for GTHP at $25000.0 in Q4 2025, $15118.0 in Q3 2025, and $15381.0 in Q2 2025.